Urban China Initiative

UCA Applauds End of the China Initiative, Calling for Accountability Under DOJ's New Guideline

Retrieved on: 
Friday, February 25, 2022
FBI, Government, Guideline, Method, Crime, UCA, Perception, Democracy, Bias, DOJ, Organization, Heart, Freedom, Review, Hatred, Assistant, Technology, Research, Program, Drug, Pharmaceutical industry, Cryptocurrency, Medical device, Urban China Initiative

WASHINGTON, Feb. 25, 2022 /PRNewswire/ -- United Chinese Americans (UCA) applauds Attorney General Garland and Assistant Attorney General Olsen for taking the first step to end the flawed "China Initiative."

Key Points: 
  • WASHINGTON, Feb. 25, 2022 /PRNewswire/ -- United Chinese Americans (UCA) applauds Attorney General Garland and Assistant Attorney General Olsen for taking the first step to end the flawed "China Initiative."
  • UCA appreciates the government for listening to the various concerns of Chinese Americans and other affected communities regarding the harm of this program.
  • UCA isthankful for the many organizations and individuals who stepped up to help redeem the integrity of America's judicial system and reclaim the promise of our democracy.
  • Many Chinese American scientists under investigation or prosecution by the China Initiative are treated as if they were spies or foreign agents.

Global T-Cell Lymphomas Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 15, 2022
Health, Other Health, Patient, CTCL, Cancer, Epidemiology, Sex, Incidence, Prevalence, Doctor of Philosophy, Urban China Initiative, NHL, Gastrointestinal tract, Lymphoma, Risk, Therapy, Cell, T-cell lymphoma, Nasal cavity, CD30, Liver, PTCL, Aggressive lymphoma, Population, Survival, Spleen, AGR, Lymph, Diagnosis, B-cell lymphoma, TCL, Organizing, Skin, NK, Vaccine, Dietary supplement, Management, Pharmaceutical industry

The "T-Cell Lymphomas - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "T-Cell Lymphomas - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • PTCL is a diverse group of aggressive lymphomas that develop from mature-stage white blood cells called T-cells and natural killer (NK) cells.
  • This is expected to increase to 34,576 diagnosed incident cases by 2030, at an Annual Growth Rate (AGR) of 2.68%.
  • T-cell lymphomas (TCL) Epidemiology Report provides an overview of the risk factors and global trends of TCL in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Urban China).

UCA Press Conference for the Victims of the DOJ's China Initiative (online) and A Silent Protest in DC

Retrieved on: 
Tuesday, January 11, 2022
Tao, Research, Ninth Street, Justice Building, Fear, Urban China Initiative, Government, Knoxville, Tennessee, DOJ, EST, Robert F. Kennedy Department of Justice Building, UCA, University, Cleveland Clinic, Pennsylvania Avenue, Congress, Knoxville News Sentinel, Professor, Cleveland, Pharmaceutical industry, Medical device, NW

WASHINGTON, Jan. 11, 2022 /PRNewswire/ -- On Wednesday, January 12, between 2:00am-3:15pm EST, United Chinese Americans (UCA) is holding a press conference highlighting the personal story, suffering and mistreatment of the China Initiative victims, at the hands of the federal law enforcement.

Key Points: 
  • WASHINGTON, Jan. 11, 2022 /PRNewswire/ -- On Wednesday, January 12, between 2:00am-3:15pm EST, United Chinese Americans (UCA) is holding a press conference highlighting the personal story, suffering and mistreatment of the China Initiative victims, at the hands of the federal law enforcement.
  • Rarely before has a press event assembled so many victims and witnesses regarding how our own government has mistreated Chinese American scientists.
  • Rarely before are so many victims willing to speak up, despite fear, about their stories.
  • Upon receiving your email, UCA will send you an invitation with the zoom link for the event.

SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China

Retrieved on: 
Wednesday, December 1, 2021
Stem Cells, Biotechnology, Other Health, Health, Pharmaceutical, Oncology, Other Science, Research, Infectious Diseases, Science, Clinical Trials, Patient, Private Securities Litigation Reform Act, Cell, Degenerative disease, Risk, Annual report, Publication, NYSE, Strategic planning, Confidentiality, Urban China Initiative, Founder, Therapy, COVID-19, U.S. Securities and Exchange Commission, Infection, Immune tolerance, APC, Research, Roche, SQZ, Doctor of Philosophy, Pharmaceutical industry

SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that its China Initiative has been accepted by the Roche Accelerator .

Key Points: 
  • SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that its China Initiative has been accepted by the Roche Accelerator .
  • Launched earlier this year, the accelerator is Roches first in-house accelerator globally and further establishes its long-term commitment to Shanghai and China.
  • Collaboration with the Roche Accelerator will support early strategic planning and potential China-based activities for the SQZ China Initiative.
  • Roche has been a strategic partner with the company since 2015 and has an ongoing collaboration with SQZ on the SQZ APC oncology program globally.

Global Neuroendocrine Tumors Epidemiology Forecast Report 2020-2021 & 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 10, 2021
Health, Oncology, Wilms' tumor, Epidemiology, Sex, Doctor of Philosophy, Paraganglioma, AGR, Risk, NETS, Urban China Initiative, Pheochromocytoma, NET, Diagnosis, Dentistry, Dietary supplement

The "Neuroendocrine Tumors - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Neuroendocrine Tumors - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The Neuroendocrine Tumors (NET) Epidemiology Report and Epidemiology provides an overview of the risk factors and global trends of NETs in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and urban China).
  • The neuroendocrine tumors epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Urban October at University of Chicago to Focus on Urgent Challenges Facing Global Cities

Retrieved on: 
Friday, September 27, 2019
Hyde Park, Chicago, University of Chicago, V-12 Navy College Training Program, Columbia University, Organizations, Urban China Initiative, Initiative on Cities

The month-long initiative brings together policy leaders, public officials, community members, and leading researchers from Chicago and around the world to focus on some of the most profound challenges facing global cities.

Key Points: 
  • The month-long initiative brings together policy leaders, public officials, community members, and leading researchers from Chicago and around the world to focus on some of the most profound challenges facing global cities.
  • Urban October at UChicago is an initiative of the University of Chicago Urban Network research institutes, policy labs, centers, and academic units at the university focused on pioneering urban science and practice.
  • Week by week, university scholars will convene key stakeholders and present new research and collaborations that will confront global urban challenges and identify emerging opportunities.
  • ABOUT UNIVERSITY OF CHICAGO URBAN NETWORK:
    The University of Chicago Urban Network brings together research institutes, policy labs, centers, and academic units from across the university that are working in urban science, practice, and civic engagement.